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Then, are not references in the liiratura about th+ posibilitv that the platelet hvperanivitv in diabetic patients is different according to the tvpe of retinqmtbv. The aim d the pmumt studv is tq evatuat4 the platelet function in insulin-dependent diebetes meliitus (IDDM) with different tvpes of retinopatv. &U&A,
The study was carried put on 20 healthy vok~ntews IHV), 20 tDDM patients withwt retirmpNbv IDWRI, 16 IDDM patients with background mtirmpathv fD6RI. 25 IDDM patkne with ischasmic-prdiative retinopathv IOIRI, and 19 IDDM patients with exudative mtirmpsthv (DERI. In blood samples. we studied platelet agOm&wnetry Msted in plate&t&h plasma -PRPand whole blood) indumd bv ADP and cdlag%n. platelet production of thromboune 6, ITx6,) and II-thmmbcgtobulin I6TG), platelet releaw of ATP. and ewthracvm uptake of tnimMiM. Em&a.
Platdet aporwntion in PRP wa* not statisticallv diem between OWUM fp<O.Zl. In whole blood. the concentration of ADP tumc#L) that inhibiis 50% the maximal pht&t aqpmqation, was 1.61 *0.07 in HV, 1.26*0.00 in DWR,0.62tO.OBinDBR,0.56iD.04inDtR,ond0.36+0.02inDER.Platelet a~rtqattm induced bv edlew! , and the other parameters of platelet activation, &wad a qualitative similar bahwkwr that the ADP-induced pIat& awranatton. Diabetes ws induced bv strepmzqtqcin. and manhined bv 3 m&hu. The drugs used were: aspirin (6 m~lKo/dav pa) as p*t&t and vascular cvclooxvgensse inhibitor, dipvrklamde (12 moKo/dsv p.0.) as prostacyclin (PGI,l rtimulatw, its aswciatia~. diiazol(200 m@Q/dav P.o.) and mmidamol 110 moKq/dav p.0.) a* wecifii inhibitors of thmmbmane flx&l production. Ewull& After 3 months of diabetic evolutirm. platelet awr46atic.n war 26.6% higher than in non-diiic rats. TX& svnthmis war incre4wd in 62%. and vascular PGI, producti~ was 42.7% tower c~npared m that of nondii animats. The inhibition of TX& exerted by aspirin, aspirk! + dipvridamak, dltazol or mopidamol was sccompained Mth an incm(io in mtinal vasculmdz~; this effects was also obtained when rata received dipvddamok, which pmduced 4" increase in PGI, rvntherir, and mainly whan the assc&t&n aspirin+ dipvridamole was used (differences between this gmup and nondbbaic rata were not statisticallvl. IZvmWnu.
We ructfjsst that the "69 of drupr that produce an increase in PGt, and/or an inhibition of TX& prcduction could avoid the retinal vascular lesions in experimental induced diabetic rats. When the aasociatkm aspirin + dtpyridamde was used. we observed the better retinal pattern in the exowimental diabetes. 
